Links to Data sources

Sr. No Display Name Type Country Last Updated
1 ARS Data Source Italy 13/06/2018

Links to Studies

Status Official Title Lead Investigator Last Updated
Finalised Drug utilization of temozolomide with or without antiepileptic drugs in patients with malignant gliomas in the Tuscany region Dr Andrea Spini 29/07/2022
Finalised Safety clinical outcomes associated with the use of Idarucizumab for severe bleeding/emergency surgery: an observational population based study Dr Rosa Gini 26/01/2022
Finalised Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines Professor Miriam Sturkenboom 26/08/2021
Finalised Utilization patterns, access to healthcare facilities and economic assessment of JAKi drugs used in rheumatoid arthritis patients in Tuscany: the LEONARDO study Professor Corrado Blandizzi 16/10/2020
Finalised First-line anticancer drugs in patients with advanced, primary Non-Small Cell Lung Cancer: drug-utilization and effectiveness studies from Tuscany Region healthcare database Dr Spini Andrea 08/08/2020
Finalised Adherence, persistence and switching patterns – once- and twice-daily direct oral anticoagulants Dr Ron Herings 19/12/2019
Finalised Pattern of use of incretin-based drugs in clinical practice Dr Roberto Giuseppe 14/02/2019
Finalised Utilisation of antiepileptic medicines in girls and women of childbearing potential - a study in three European countries Dr Charlton Rachel 15/10/2018
Finalised ASPIrin use and colorectal CANcer risk Dr Leonardo Ventura 25/07/2018
Finalised Identification of type 2 diabetes cases in a set of databases participating to the EMIF project Dr Roberto Giuseppe 11/12/2017
Finalised ADVANCE POC Study Protocol - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case. Coverage rates of acellular and whole-cell pertussis-containing vaccines in preschool children Dr Hanne-Dorthe Emborg 24/11/2017
Finalised ADVANCE POC I Risk pillar - Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of safety outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children Dr Daniel Weibel 22/11/2017
Finalised Pattern of use of intravitreal drugs with antiangiogenic properties for age-related macular degeneration and other vascular retinopathies Dr Rosa Gini 28/11/2016
Finalised Comparative effectiveness of insulines vs analogues to prevent complications of diabetes Dr Rosa Gini 08/07/2014
Ongoing CONSIGN study: COVID-19 infection and medicines in pregnancy - a multinational registry based study Professor Hedvig Nordeng 16/08/2022
Ongoing Patterns of anti-CGRP mAbs use and triptan consumption before and after anti-CGRP treatment initiation: a descriptive drug utilization study in Tuscany region, Italy Dr Giulia Hyeraci 29/07/2022
Ongoing A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources (COVID-19) Dr Cristina Rebordosa 10/05/2022
Ongoing Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe (COVID-19) Professor Henrik Toft Sørensen 31/01/2022
Ongoing Monitoring safety of Spikevax in pregnancy: an observational study using routinely collected health data in five European countries (COVID-19) Professor Henrik Toft Sørensen 31/01/2022
Ongoing Exposure to SSRI/SNRI and depression in pregnancy and long-term childhood outcomes: the effect of modifying factors Dr Maria Loane 04/10/2021
Ongoing Novel statistics to handle rare diseases and small sample sizes using Bayesian techniques: Application to Multiple Sclerosis (MS) and Systemic Lupus Erythematosus (SLE) in pregnancy Dr Christine Damase-Michel 04/10/2021
Ongoing Methods for controlling by indication for prescriptions: application to medications for neuropathic pain Dr Christine Damase-Michel 04/10/2021
Ongoing Data source heterogeneity in multi-database pharmacoepidemiologic studies: a scoping review Dr Romin Pajouheshnia 04/03/2021
Ongoing ACCESS template protocol for safety of COVID-19 vaccines Professor Miriam Sturkenboom 19/02/2021
Ongoing Estimating prevalence and incidence of acute myocardial infarction in a set of heterogeneous sources of observational health data collaborating in the EMIF Platform Dr Roberto Giuseppe 14/02/2019
Ongoing EMIF Use Case 17 - Investigating the relationship in paediatric population between dosing of antibiotics (prescribed, dispensed or administered) and patient’s weight. Dr Luigi Cantarutti 31/01/2019
Planned Description of international collaboration in the area of medicines use and effects in COVID-19 affected pregnancies (CONSIGN-International)) Professor Miriam Sturkenboom 20/07/2022
Planned ANALYSIS OF TREATMENT PATTERNS WITH DISEASE MODIFYING THERAPIES (DMTs) AMONG PATIENTS WITH MULTIPLE SCLEROSIS Professor Ersilia Lucenteforte 11/07/2022
Planned Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination Professor Miriam Sturkenboom 29/06/2022
Planned Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen Dr Elisa Martín Merino 17/06/2022
Planned Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: utilization and prescribing trends Dr Miriam Sturkenboom 21/02/2022
Planned Impact of EU label changes and revised pregnancy prevention programme for medicinal products containing valproate: utilisation and prescribing trends Professor Olaf Klungel 21/02/2022
Planned The BRodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) study in electronic healthcare databases Professor Jesper Hallas 05/10/2021
Planned Demonstrating solutions for studying intermittent medication exposures in diseases with episodic manifestations during pregnancy: application to medication for migraine in pregnancy Professor Hedvig Nordeng 04/10/2021
Planned Cohort study to quantify the risk of glaucoma with intravitreal VEGF inhibitors (bevacizumab, ranibizumab, aflibercept) Dr Andrea Spini 13/09/2021
Planned Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources Professor Miriam Sturkenboom 26/08/2021
Planned Comparative Effectiveness and Safety of Drugs used in Rare Neuromuscular and Neurodegenerative Diseases Ms Ursula Kirchmayer 10/11/2020
Planned Impact of the COVID-19 pandemic in a cohort of anticoagulant users: a descriptive drug utilization study based on data from the Tuscany Healthcare administrative database Dr Ippazio Cosimo Antonazzo 23/09/2020
Planned Time to treatment intensification in patients receiving metformin+incretin-based medicines versus metformin+other hypoglicemics Dr Roberto Giuseppe 14/02/2019
Planned Exposure and coverage to routine schedule vaccines in different EU countries Professor Miriam Sturkenboom 02/02/2019